Background illustration for clinical trials search

Uterine Cancer Clinical Trials

Browse 340 uterine cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Featured

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRĪ±)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Providence RI, New Haven CT, Lebanon NH, Bay Shore NY,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06890338

Phase2, Recruiting
Active & Responsive

Liquid Biopsy Evaluation and Repository Development at Princess Margaret

for
Cancer, Breast Cancer, Lung Cancer, Colon Cancer,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT03702309

Recruiting
Active & Responsive

Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome

for
Cascade Testing, Lynch Syndrome, Decision Making,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT07106359

Recruiting
Active & Responsive

PROton Therapy for Post Surgical Treatment of GYNecologic Cancer

for
Cervical Cancer, Uterine Cancer, Endometrial Cancer
Location: Voorhees Township NJ, Philadelphia PA, Lancaster PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: Female

Age: 18+

Code: NCT05758688

Phase2, Recruiting
Active & Responsive

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Location: Brewer ME, Scarborough ME, Boston MA, Providence RI,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07198074

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Building Connections

for
Cancer Colorectal, Cancer Cervix, Depression, Anxiety, Obesity
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70+

Code: NCT07091032

Recruiting
Active & Responsive

ImpRoving hEalth behaviourS for LIfe After ENdometrial CancEr Trial

for
Endometrial Cancer
Location: Toronto, Edmonton
Sponsor: University of Alberta

Sex: Female

Age: 18+

Code: NCT06038032

Recruiting
Active & Responsive

Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

for
Cervical Cancer, Metastatic Cervical Cancer
Location: Hackensack NJ, Washington D.C. DC, Augusta GA
Sponsor: Georgetown University

Sex: Female

Age: 18+

Code: NCT04865887

Phase2, Recruiting
Active & Responsive

Sentinel Node Biopsy in Endometrial Cancer

for
Endometrial Cancer Stage I, Sentinel Lymph Node, Surgery
Location: Houston TX
Sponsor: Queensland Centre for Gynaecological Cancer

Sex: Female

Age: 18+

Code: NCT04073706

Phase3, Recruiting
Active & Responsive

Project CONTINUITY: Promoting Evidence-Based Cancer Screening Among Underserved Women

for
Cervical Cancer Screening Methods
Location: Gainesville FL
Sponsor: University of Florida

Sex: Female

Age: 25 - 65

Code: NCT05390567

Recruiting
Active & Responsive

FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

for
Cervical Cancer
Location: Quebec, Toronto
Sponsor: University Health Network, Toronto

Sex: Female

Age: 18 - 40

Code: NCT04016389

Recruiting
Active & Responsive

Unidos Contra el VPH

for
Human Papilloma Virus (HPV), Cervical Cancers
Location: El Paso TX
Sponsor: University of Texas at Austin

Sex: Female

Age: 30 - 65

Code: NCT06825689

Recruiting
Active & Responsive

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

for
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy),
Location: Stony Brook NY, New York NY, Montreal, Baltimore MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06535607

Phase2, Recruiting
Active & Responsive

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

for
Endometrial Cancer, Ovarian Cancer, Ovarian Cancer Metastatic,
Location: Hackensack NJ, Fairfax VA, Buffalo NY, Cleveland OH,
Sponsor: Whitehawk Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07444814

Phase1, Recruiting
Active & Responsive

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

for
Cervical Cancer, Human Papilloma Virus (HPV)
Location: Gainesville FL
Sponsor: University of Florida

Sex: Female

Age: 18 - 70+

Code: NCT07214584

Recruiting
Active & Responsive

Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs

for
Cervical Cancer, Screening
Location: Cincinnati OH
Sponsor: International Agency for Research on Cancer

Sex: Female

Age: 25 - 49

Code: NCT06042543

Recruiting
Active & Responsive

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

for
Endometrial Cancer
Location: New York NY, Albany NY, Doylestown PA, Brandywine MD,
Sponsor: Faeth Therapeutics

Sex: Female

Age: 18+

Code: NCT06463028

Phase2, Recruiting
Active & Responsive

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

for
Ovarian Cancer, Fallopian Tube Cancer
Location: Boston MA, New York NY, Philadelphia PA, St Louis MO,
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT05287451

Recruiting
Active & Responsive

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

for
Platinum-resistant Ovarian Cancer,
Location: Stony Brook NY, Greenville NC, Silver Spring MD,
Sponsor: Genelux Corporation

Sex: Female

Age: 18+

Code: NCT05281471

Phase3, Recruiting
Active & Responsive

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Scarborough ME, Worcester MA, Hartford CT, Norwalk CT,
Sponsor: Massive Bio, Inc.

Sex: All

Age: 0+

Code: NCT03452774

Recruiting